Pronóstico del mercado de asparaginasa de América del Sur hasta 2028: impacto de COVID-19 y análisis regional por tipo (Escherichia Coli, Erwinia Chrysanthemi, pegilada y otros), aplicación (terapéutica, procesamiento de alimentos y otros) e industria de uso final (atención médica y alimentación) Fabricación)

Se espera que el mercado de asparaginasa SAM crezca de 32,29 millones de dólares en 2022 a 73,24 millones de dólares en 2028; Se estima que crecerá a una tasa compuesta anual del 14,6 % entre 2022 y 2028.

Lanzamientos y aprobaciones de nuevos productos

Las industrias farmacéutica y alimentaria se están desarrollando constantemente a un ritmo significativo debido a que la creciente demanda de una gran población ha aumentado el desarrollo de nuevos productos, los lanzamientos de productos y las aprobaciones a nivel regional. Además, los principales actores del mercado participan en actividades de investigación y desarrollo para garantizar la innovación y el desarrollo de productos eficientes. En los últimos años se han producido diversos acontecimientos, como lanzamientos y aprobaciones de productos en el mercado, que probablemente crearán amplias oportunidades en el mercado. Por ejemplo, en julio de 2021, Ligand Pharmaceuticals Incorporated se asoció con Jazz Pharmaceuticals Plc para lanzar Rylaze (asparaginasa Erwinia Chrysanthemi (recombinante)-rywn), también conocida como JZP458. Rylaze es una asparaginasa de erwinia recombinante que se utiliza como componente de un régimen quimioterapéutico de múltiples agentes para el tratamiento de la leucemia linfoblástica aguda (LLA) o el linfoma linfoblástico (LBL) en pacientes adultos y pediátricos de 1 mes o más que han desarrollado hipersensibilidad a derivados de E. coli. asparaginasa. De manera similar, en agosto de 2020, Lonza amplió la capacidad microbiana y amplió la asociación a largo plazo con Servier Pharmaceuticals, Inc. para la fabricación de API de l-asparaginasa. La nueva instalación proporcionará fabricación comercial de mediana escala a múltiples clientes y atenderá las crecientes necesidades de Servier, una compañía farmacéutica internacional independiente y socio de Lonza a largo plazo. Por lo tanto, es probable que el aumento en el desarrollo de nuevos productos, lanzamientos y otras colaboraciones estratégicas entre los actores del mercado cree amplias oportunidades e impulse el crecimiento del mercado en los próximos años.

< strong>Descripción general del mercado

El mercado de asparaginasa SAM está segmentado en Brasil, Argentina y el resto de SAM. Brasil dominó el mercado en 2022. Según el informe de la Organización Mundial de la Salud, en 2020 se notificaron en Brasil 11.445 nuevos casos de linfoma no Hodgkin y 11.363 nuevos casos de leucemia. Ha habido un desarrollo en las instalaciones y productos de atención médica junto con la creciente prevalencia de Leucemia y linfoma en Brasil. Según un informe de la Biblioteca Nacional de Medicina, el Ministerio de Salud de Brasil adquirió una nueva l-asparaginasa producida por Beijing SL Pharmaceutical (China) con el nombre comercial de Leuginase en 2017. Además, Brasil tiene la segunda industria procesadora de alimentos más grande de América del Norte y Sudamérica, después de Estados Unidos. El país también tiene la segunda industria agrícola más grande y también exporta la mayoría de los alimentos e ingredientes a los países vecinos. Brasil ha experimentado un crecimiento significativo en la industria de procesamiento de alimentos, lo que ha creado aún más la demanda de asparaginasa. Por ejemplo, según la Asociación Brasileña de Procesadores de Alimentos, la industria brasileña de procesamiento de alimentos generó ingresos de 171 mil millones de dólares en 2021, lo que representa un aumento del 16,9% en comparación con 2020. Así, la creciente prevalencia de leucemia y linfoma, junto con con un aumento en la aplicación de asparaginasa en el sector agrícola y agrícola. Se espera que las industrias alimentarias del país proliferen el crecimiento del mercado de asparaginasa durante el período previsto.

Ingresos del mercado de asparaginasa SAM y pronóstico para 2028 (USD Millones)

Segmentación del mercado de asparaginasa SAM

< p>El mercado de asparaginasa SAM está segmentado según el tipo, la aplicación, la industria de uso final y el país.

Según el tipo, el mercado de asparaginasa SAM está segmentadas en escherichia coli, erwinia chrysanthemi, pegiladas y otras. El segmento de Escherichia coli tuvo la mayor participación de mercado en 2022. Según la aplicación, el mercado de asparaginasa SAM se segmenta en terapéutico, procesamiento de alimentos y otros. El segmento terapéutico tuvo la mayor participación de mercado en 2022. El segmento terapéutico se clasifica además en leucemia linfoblástica aguda, linfoma linfoblástico y otros. Basado en la industria de uso final, el mercado de asparaginasa SAM se divide en atención médica y fabricación de alimentos. El segmento de atención médica tuvo la mayor participación de mercado en 2022. Según el país, el mercado de asparaginasa SAM se ha clasificado en Brasil, Argentina y el resto de SAM. Nuestro análisis regional indica que Brasil dominó el mercado en 2022. Biovendor, LLC; Enzimas Creativas; Jazz Pharmaceuticals, Inc.; medac GMBH; Servier Pharmaceuticals LLC; Taj Pharmaceuticals Limited; y United Biotech (P) Limited son las empresas líderes que operan en el mercado de asparaginasa SAM.

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 SAM Asparaginase Market – By Type

1.3.2 SAM Asparaginase Market – By Application

1.3.3 SAM Asparaginase Market – By End-Use Industry

1.3.4 SAM Asparaginase Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. SAM Asparaginase Market – Market Landscape

4.1 Overview

4.2 SAM PEST Analysis

4.3 Experts Opinion

5. SAM Asparaginase Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidences of Leukemia and Increasing Usage Application

5.1.2 Significant Growth of Pharmaceutical and Food Industry

5.2 Market Restraints

5.2.1 Side Effects Associated With Use of Asparaginase

5.3 Market Opportunities

5.3.1 New Product Launches and Approvals

5.4 Future Trends

5.4.1 Increase in R&D Activities and Investment by Market Players

5.5 Impact Analysis

6. Asparaginase Market– SAM Analysis

6.1 SAM Asparaginase Market Revenue Forecasts and Analysis

7. SAM Asparaginase Market Analysis – By Type

7.1 Overview

7.2 By Type: SAM Market Revenue and Forecast Analysis (US$ Million)

7.2.1 Escherichia Coli

7.2.1.1 Overview

7.2.1.2 Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)

7.2.2 Erwinia Chrysanthemi

7.2.2.1 Overview

7.2.2.2 Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)

7.2.3 Pegylated

7.2.3.1 Overview

7.2.3.2 Pegylated Market Revenue and Forecast to 2028 (US$ Million)

7.2.4 Others

7.2.4.1 Overview

7.2.4.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. SAM Asparaginase Market Analysis – By Application

8.1 Overview

8.2 By Application: SAM Market Revenue and Forecast Analysis (US$ Million)

8.2.1 Therapeutic

8.2.1.1 Overview

8.2.1.2 Therapeutic Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.3 Acute Lymphoblastic Leukaemia (ALL)

8.2.1.3.1 Acute lymphoblastic leukemia Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.4 Lymphoblastic Lymphoma (LBL)

8.2.1.4.1 Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.5 Others

8.2.1.5.1 Others Market Revenue and Forecast to 2028 (US$ Million)

8.2.2 Food Processing

8.2.2.1 Overview

8.2.2.2 Food Processing Market Revenue and Forecast to 2028 (US$ Million)

8.2.3 Others

8.2.3.1 Overview

8.2.3.2 Others Market Revenue and Forecast to 2028 (US$ Million)

9. SAM Asparaginase Market Analysis – By End-use Industry

9.1 By End-Use: SAM Market Revenue and Forecast Analysis (US$ Million)

9.1.1 Healthcare

9.1.1.1 Overview

9.1.1.2 Healthcare Market Revenue and Forecast to 2028 (US$ Million)

9.1.2 Food Manufacturing

9.1.2.1 Overview

9.1.2.2 Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)

10. SAM Asparaginase Market – Country Analysis

10.1 Overview

10.1.1 SAM: Asparaginase Market, by Country, 2021 & 2028 (%)

10.1.1.1 Brazil: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.1.1 Overview

10.1.1.1.2 Brazil: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.1.3 Brazil: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.1.1.1.4 Brazil: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.1.1.1.4.1 Brazil: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.1.1.1.5 Brazil: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

10.1.1.2 Argentina: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.2.1 Overview

10.1.1.2.2 Argentina: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.2.3 Argentina: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.1.1.2.4 Argentina: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.1.1.2.4.1 Argentina: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.1.1.2.5 Argentina: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

10.1.1.3 Rest of SAM: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.3.1 Overview

10.1.1.3.2 Rest of SAM: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.3.3 Rest of SAM: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.1.1.3.4 Rest of SAM: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.1.1.3.4.1 Rest of SAM: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.1.1.3.5 Rest of SAM: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

11. Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Servier Pharmaceuticals LLC

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Biovendor, LLC

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Creative Enzymes

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Taj Pharmaceuticals Limited

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 medac GMBH

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Jazz Pharmaceuticals, Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 United Biotech (P) Limited

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. SAM Asparaginase Market– Revenue and Forecast to 2028 (US$ Mn)

Table 2. Brazil: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3. Brazil: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4. Brazil: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5. Brazil: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6. Argentina: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7. Argentina: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8. Argentina: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9. Argentina: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10. Rest of SAM: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11. Rest of SAM: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12. Rest of SAM: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13. Rest of SAM: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 14. Recent Inorganic Growth Strategies

Table 15. Recent Organic Growth Strategies

Table 16. Glossary of Terms

LIST OF FIGURES

Figure 1. SAM Asparaginase Market Segmentation

Figure 2. SAM Asparaginase Market Segmentation, by Country

Figure 3. SAM Asparaginase Market Overview

Figure 4. SAM Asparaginase Market, By Type

Figure 5. SAM Asparaginase Market, By Country

Figure 7. SAM: PEST Analysis

Figure 8. Experts Opinion

Figure 9. SAM Asparaginase Market Impact Analysis of Drivers and Restraints

Figure 10. SAM Asparaginase Market – Revenue Forecasts and Analysis

Figure 11. By Type: SAM Market Analysis and Forecast 2021 and 2028 (%)

Figure 12. SAM Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. SAM Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. SAM Pegylated Market Revenue and Forecast to 2028 (US$ Million)

Figure 15. SAM Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 16. By Application: SAM Market Analysis and Forecast 2021 and 2028 (%)

Figure 17. SAM Therapeutic Market Revenue and Forecast to 2028 (US$ Million)

Figure 18. SAM Acute Lymphoblastic Leukemia Market Revenue and Forecast to 2028 (US$ Million)

Figure 19. SAM Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)

Figure 20. SAM Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 21. SAM Food Processing Market Revenue and Forecast to 2028 (US$ Million)

Figure 22. SAM Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 23. By End-Use: SAM Market Analysis and Forecast 2021 and 2028 (%)

Figure 24. SAM Healthcare Market Revenue and Forecast to 2028 (US$ Million)

Figure 25. SAM Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)

Figure 26. SAM: Asparaginase Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 27. SAM: Asparaginase Market, by Country, 2021 & 2028 (%)

Figure 28. Brazil: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 29. Argentina: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 30. Rest of SAM: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM asparaginase market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the SAM asparaginase market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the asparaginase market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
South America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
South and Central America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission,..	May 2022
South and Central America In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syring..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000